Condition

Relapsed Acute Myeloid Leukemia (AML) clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• CD64 CAR T Therapy for Adults with Relapsed or Refractory AML

  This phase 1 study tests a patient’s own CD64-directed CAR T cells to see if they can be safely given and potentially help adults with relapsed or refractory AML.

  Recruiting Phase 1 University of Colorado, Denver · Aurora, Colorado · NCT07347418

• Testing AUTX-703 for advanced blood cancers

  This study is testing a new drug called AUTX-703 to see if it can safely help people with advanced blood cancers like acute myeloid leukemia and myelodysplastic syndromes.

  Recruiting at 9 sites Phase 1 Auron Therapeutics, Inc. · Duarte, California and 8 other locations · NCT06846606

Related topics

Quick answers

How many Relapsed Acute Myeloid Leukemia (AML) clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →